|
US20100111856A1
(en)
|
2004-09-23 |
2010-05-06 |
Herman Gill |
Zirconium-radiolabeled, cysteine engineered antibody conjugates
|
|
USRE47223E1
(en)
*
|
2005-06-20 |
2019-02-05 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
CL2008001334A1
(es)
|
2007-05-08 |
2008-09-22 |
Genentech Inc |
Anticuerpo anti-muc16 disenado con cisteina; conjugado que lo comprende; metodo de produccion; formulacion farmaceutica que lo comprende; y su uso para tratar el cancer.
|
|
EP2185188B1
(en)
|
2007-08-22 |
2014-08-06 |
Medarex, L.L.C. |
Site-specific attachment of drugs or other agents to engineered antibodies with c-terminal extensions
|
|
US8937161B2
(en)
*
|
2007-10-19 |
2015-01-20 |
Genentech, Inc. |
Cysteine engineered anti-TENB2 antibodies and antibody drug conjugates
|
|
BRPI0910810A2
(pt)
|
2008-07-15 |
2019-09-24 |
Genentech Inc |
conjugados derivados de antraciclina, veículo polimérico, anticorpo, peptídeo ou proteína, veículo t-[cho]m, composições farmacêuticas, métodos de tratamento do câncer ou de distúrbios da proliferação celular, derivado de antraciclina, composto conjugado droga-anticorpo, uso, artigo de manufatura e método de produção de um composto conjugado droga-anticorpo"
|
|
CA2745798A1
(en)
|
2008-12-05 |
2010-06-10 |
The Government Of The U.S.A., As Represented By The Secretary, Departmen T Of Health & Human Services |
Blocking mesothelin peptide fragments
|
|
WO2010096394A2
(en)
|
2009-02-17 |
2010-08-26 |
Redwood Biosciences, Inc. |
Aldehyde-tagged protein-based drug carriers and methods of use
|
|
CA2752884A1
(en)
|
2009-02-27 |
2010-09-02 |
Genentech, Inc. |
Methods and compositions for protein labelling
|
|
US20110020323A1
(en)
|
2009-07-15 |
2011-01-27 |
Tim Beaumont |
Gram-positive bacteria specific binding compounds
|
|
EP2554669B1
(en)
|
2010-03-26 |
2018-09-19 |
Kyowa Hakko Kirin Co., Ltd. |
Novel antibody having modification site introduced therein, and antibody fragment
|
|
CA3002192C
(en)
*
|
2010-03-26 |
2023-03-07 |
Memorial Sloan-Kettering Cancer Center |
Antibodies to muc16 and methods of use thereof
|
|
RS52983B
(sr)
|
2010-04-15 |
2014-02-28 |
Spirogen Sárl |
Pirolobenzodiazepini i njihovi konjugati
|
|
CN119552249A
(zh)
*
|
2010-06-08 |
2025-03-04 |
基因泰克公司 |
半胱氨酸改造的抗体和偶联物
|
|
JP5889912B2
(ja)
|
2010-11-17 |
2016-03-22 |
ジェネンテック， インコーポレイテッド |
アラニニルメイタンシノール抗体コンジュゲート
|
|
PH12013501323A1
(en)
*
|
2010-12-20 |
2013-08-28 |
Genentech Inc |
Anti-mesothelin antibodies and immunoconjugates
|
|
CA2824143C
(en)
|
2011-01-14 |
2018-12-18 |
Redwood Bioscience, Inc. |
Aldehyde-tagged immunoglobulin polypeptides and method of use thereof
|
|
TWI617555B
(zh)
|
2011-02-15 |
2018-03-11 |
免疫原公司 |
細胞毒性苯并二氮呯衍生物
|
|
EP3138581B1
(en)
|
2011-03-17 |
2019-01-02 |
The University of Birmingham |
Re-directed immunotherapy
|
|
UY34317A
(es)
|
2011-09-12 |
2013-02-28 |
Genzyme Corp |
Anticuerpo antireceptor de célula T (alfa)/ß
|
|
HUE025661T2
(en)
|
2011-10-14 |
2016-04-28 |
Medimmune Ltd |
Pyrrolobenzodiazepines and their conjugates
|
|
ES2739808T3
(es)
|
2011-10-27 |
2020-02-04 |
Genmab As |
Producción de proteínas heterodiméricas
|
|
EA034989B1
(ru)
|
2011-10-28 |
2020-04-15 |
Тева Фармасьютикал Австралия Пти Лтд |
Полипептидная конструкция для применения при лечении рака, включающая аттенуированный альфа-интерферон
|
|
JP2015502397A
(ja)
|
2011-12-23 |
2015-01-22 |
ファイザー・インク |
部位特異的コンジュゲーションのための操作された抗体定常領域、ならびにそのための方法および使用
|
|
WO2013109994A1
(en)
|
2012-01-20 |
2013-07-25 |
Sea Lane Biotechnologies, Llc |
Surrobody cojugates
|
|
US9814782B2
(en)
*
|
2012-02-24 |
2017-11-14 |
Alteogen Inc. |
Modified antibody in which motif comprising cysteine residue is bound, modified antibody-drug conjugate comprising the modified antibody, and production method for same
|
|
WO2013177481A1
(en)
|
2012-05-25 |
2013-11-28 |
Immunogen, Inc. |
Benzodiazepines and conjugates thereof
|
|
US9790268B2
(en)
|
2012-09-12 |
2017-10-17 |
Genzyme Corporation |
Fc containing polypeptides with altered glycosylation and reduced effector function
|
|
JP6367204B2
(ja)
|
2012-10-12 |
2018-08-01 |
メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ |
結合用のピロロベンゾジアゼピン誘導体の合成および中間体
|
|
CA2887895C
(en)
|
2012-10-12 |
2019-10-29 |
Adc Therapeutics Sarl |
Pyrrolobenzodiazepine-anti-cd19 antibody conjugates
|
|
SI2766048T1
(sl)
|
2012-10-12 |
2015-03-31 |
Spirogen Sarl |
Pirolobenzodiazepini in njihovi konjugati
|
|
TR201808051T4
(tr)
|
2012-10-12 |
2018-06-21 |
Adc Therapeutics Sa |
Pirrolobenzodiazepin antikor konjugatları.
|
|
HUE041274T2
(hu)
|
2012-10-12 |
2019-05-28 |
Adc Therapeutics Sa |
Pirrolobenzodiazepin-anti-PSMA-antitest konjugátumok
|
|
WO2014057114A1
(en)
|
2012-10-12 |
2014-04-17 |
Adc Therapeutics Sàrl |
Pyrrolobenzodiazepine-anti-psma antibody conjugates
|
|
EP2906297B1
(en)
|
2012-10-12 |
2017-12-06 |
ADC Therapeutics SA |
Pyrrolobenzodiazepine-antibody conjugates
|
|
LT2906248T
(lt)
|
2012-10-12 |
2019-02-11 |
Medimmune Limited |
Pirolobenzodiazepinai ir jų konjugatai
|
|
CN105102004B
(zh)
|
2012-10-12 |
2019-01-25 |
Adc疗法责任有限公司 |
吡咯并苯并二氮杂卓-抗cd22抗体结合物
|
|
WO2014089177A2
(en)
|
2012-12-04 |
2014-06-12 |
Massachusetts Institute Of Technology |
Compounds, conjugates and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines
|
|
EP2934602B1
(en)
|
2012-12-19 |
2019-02-27 |
Genentech, Inc. |
Methods and compositions for radiohalogen protein labeling
|
|
CA2894959C
(en)
|
2012-12-21 |
2022-01-11 |
Spirogen Sarl |
Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases
|
|
CN110452242A
(zh)
|
2012-12-21 |
2019-11-15 |
麦迪穆有限责任公司 |
吡咯并苯并二氮杂卓及其结合物
|
|
CN103933575B
(zh)
|
2013-01-23 |
2017-09-29 |
上海新理念生物医药科技有限公司 |
一种三齿型连接子及其应用
|
|
WO2014124316A2
(en)
*
|
2013-02-08 |
2014-08-14 |
Irm Llc |
Specific sites for modifying antibodies to make immunoconjugates
|
|
ME03394B
(me)
|
2013-02-22 |
2020-01-20 |
Medimmune Ltd |
Antidllз-antitelo-pbd konjugati i nihovа upotreba
|
|
HK1219422A1
(zh)
|
2013-02-28 |
2017-04-07 |
Immunogen, Inc. |
包含细胞结合剂及细胞毒素剂的轭合物
|
|
EP2961435B1
(en)
|
2013-02-28 |
2019-05-01 |
ImmunoGen, Inc. |
Conjugates comprising cell-binding agents and cytotoxic agents
|
|
JOP20140049B1
(ar)
*
|
2013-03-08 |
2021-08-17 |
Lilly Co Eli |
أجسام مضادة ترتبط بـ il-23
|
|
IL319584A
(en)
|
2013-03-11 |
2025-05-01 |
Genzyme Corp |
Polypeptides with hyperglycosidic bonds
|
|
MX363787B
(es)
|
2013-03-13 |
2019-04-03 |
Medimmune Ltd |
Pirrolobenzodiazepinas y conjugados de los mismos.
|
|
ES2731779T3
(es)
|
2013-03-13 |
2019-11-19 |
Medimmune Ltd |
Pirrolobenzodiazepinas y conjugados de las mismas
|
|
MX362970B
(es)
|
2013-03-13 |
2019-02-28 |
Medimmune Ltd |
Pirrolobenzodiazepinas y conjugados de las mismas.
|
|
US10570151B2
(en)
|
2013-03-15 |
2020-02-25 |
Regeneron Pharmaceuticals, Inc. |
Biologically active molecules, conjugates thereof, and therapeutic uses
|
|
US11117975B2
(en)
|
2013-04-29 |
2021-09-14 |
Teva Pharmaceuticals Australia Pty Ltd |
Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B
|
|
UA113129C2
(xx)
|
2013-04-29 |
2016-12-12 |
|
ЗЛИТА КОНСТРУКЦІЯ АНТИТІЛО ПРОТИ CD38 З ОСЛАБЛЕНИМ ІНТЕРФЕРОНОМ АЛЬФА-2b
|
|
HUE050451T2
(hu)
|
2013-05-31 |
2020-12-28 |
Genentech Inc |
Anti-fal-teichonsav antitestek és konjugátumok
|
|
US9884126B2
(en)
|
2013-05-31 |
2018-02-06 |
Genentech, Inc. |
Anti-wall teichoic antibodies and conjugates
|
|
US9803002B2
(en)
|
2013-05-31 |
2017-10-31 |
Genentench, Inc. |
Anti-wall teichoic antibodies and conjugates
|
|
JP6208864B2
(ja)
*
|
2013-06-24 |
2017-10-04 |
エービーエルバイオ |
安定性が改善された抗体−薬物結合体およびこれの用途
|
|
EP3018143B1
(en)
|
2013-07-03 |
2019-05-29 |
Seoul National University R&DB Foundation |
Chicken antibody transformed into cysteine and site-specific conjugation using same
|
|
US10023652B2
(en)
*
|
2013-07-09 |
2018-07-17 |
Board Of Regents Of The University Of Nebraska |
Method of targeting glycoproteins to treat cancer
|
|
AU2014307080B2
(en)
|
2013-08-12 |
2018-06-07 |
Genentech, Inc. |
1-(chloromethyl)-2,3-dihydro-1H-benzo(E)indole dimer antibody-drug conjugate compounds, and methods of use and treatment
|
|
EA038192B1
(ru)
|
2013-08-26 |
2021-07-21 |
Регенерон Фармасьютикалз, Инк. |
Фармацевтические композиции, содержащие диастереомеры макролида, способы их синтезирования и терапевтическое применение
|
|
KR20160044042A
(ko)
|
2013-08-28 |
2016-04-22 |
스템센트알엑스 인코포레이티드 |
부위-특이적 항체 접합 방법 및 조성물
|
|
GB201317981D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
EP3054985B1
(en)
|
2013-10-11 |
2018-12-26 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
GB201317982D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
WO2015052535A1
(en)
|
2013-10-11 |
2015-04-16 |
Spirogen Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
|
US10010624B2
(en)
|
2013-10-11 |
2018-07-03 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
JP6515111B2
(ja)
|
2013-11-06 |
2019-05-22 |
アッヴィ・ステムセントルクス・エル・エル・シー |
新規の抗クローディン抗体および使用方法
|
|
EP3072907B1
(en)
*
|
2013-11-19 |
2019-02-20 |
Remegen, Ltd |
Anti-her2 antibody and conjugate thereof
|
|
PE20160993A1
(es)
|
2013-12-12 |
2016-10-14 |
Abbvie Stemcentrx Llc |
Nuevos anticuerpos anti-dpep3 y metodos de uso
|
|
WO2015095223A2
(en)
|
2013-12-16 |
2015-06-25 |
Genentech, Inc. |
Peptidomimetic compounds and antibody-drug conjugates thereof
|
|
EA201691023A1
(ru)
|
2013-12-16 |
2016-10-31 |
Дженентек, Инк. |
Пептидомиметические соединения и их конъюгаты антитела с лекарственным средством
|
|
CN105828840B
(zh)
|
2013-12-16 |
2020-08-04 |
基因泰克公司 |
1-(氯甲基)-2,3-二氢-1H-苯并[e]吲哚二聚体抗体-药物缀合物化合物及使用和治疗方法
|
|
EA201691683A1
(ru)
|
2014-02-21 |
2017-04-28 |
ЭББВИ СТЕМСЕНТРКС ЭлЭлСи |
Антитела против dll3 и конъюгаты антитело-лекарственное средство для применения при меланоме
|
|
CN104788566A
(zh)
*
|
2014-03-11 |
2015-07-22 |
南京任诺药业有限公司 |
用于构建放射性同位素偶联标记的ADC药物的改造抗体IgG1-CH-V280C
|
|
CN104672330A
(zh)
*
|
2014-03-11 |
2015-06-03 |
南京任诺药业有限公司 |
用于构建放射性同位素偶联标记的ADC药物的改造抗体IgG1-CH-N267C
|
|
CN116333148A
(zh)
|
2014-03-19 |
2023-06-27 |
建新公司 |
靶向模块的位点特异性糖工程化
|
|
GB201406767D0
(en)
|
2014-04-15 |
2014-05-28 |
Cancer Rec Tech Ltd |
Humanized anti-Tn-MUC1 antibodies anf their conjugates
|
|
HRP20192254T1
(hr)
|
2014-04-25 |
2020-03-06 |
Pierre Fabre Medicament |
Konjugat antitijela i lijeka i njegova upotreba u liječenju karcinoma
|
|
US10202458B2
(en)
|
2014-04-25 |
2019-02-12 |
Pierre Fabre Medicament |
IGF-1R antibody and its use as addressing vehicle for the treatment of cancer
|
|
BR112016024619A2
(pt)
|
2014-04-25 |
2017-10-10 |
Pf Medicament |
conjugado de anticorpo ao igf-1r-fármaco e seu uso para o tratamento de câncer
|
|
UA119352C2
(uk)
|
2014-05-01 |
2019-06-10 |
Тева Фармасьютикалз Острейліа Пті Лтд |
Комбінація леналідоміду або помалідоміду і конструкції анти-cd38 антитіло-атенуйований інтерферон альфа-2b та спосіб лікування суб'єкта, який має cd38-експресуючу пухлину
|
|
WO2016008112A1
(en)
*
|
2014-07-16 |
2016-01-21 |
Medshine Discovery Inc. |
Linkers and application towards adc thereof
|
|
AU2015294389B2
(en)
|
2014-07-24 |
2021-04-29 |
Genentech, Inc. |
Methods of conjugating an agent to a thiol moiety in a protein that contains at least one trisulfide bond
|
|
TW201617368A
(zh)
|
2014-09-05 |
2016-05-16 |
史坦森特瑞斯公司 |
新穎抗ｍｆｉ２抗體及使用方法
|
|
JP6531166B2
(ja)
|
2014-09-10 |
2019-06-12 |
メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ |
ピロロベンゾジアゼピン及びそのコンジュゲート
|
|
EP3191134B1
(en)
|
2014-09-12 |
2019-11-20 |
Genentech, Inc. |
Anthracycline disulfide intermediates, antibody-drug conjugates and methods
|
|
JP2017531620A
(ja)
|
2014-09-12 |
2017-10-26 |
ジェネンテック， インコーポレイテッド |
システイン操作抗体及びコンジュゲート
|
|
GB201416112D0
(en)
|
2014-09-12 |
2014-10-29 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
WO2016044560A1
(en)
|
2014-09-17 |
2016-03-24 |
Genentech, Inc. |
Pyrrolobenzodiazepines and antibody disulfide conjugates thereof
|
|
CA2957148A1
(en)
|
2014-09-17 |
2016-03-24 |
Genentech, Inc. |
Immunoconjugates comprising anti-her2 antibodies and pyrrolobenzodiazepines
|
|
PT3204425T
(pt)
|
2014-10-09 |
2020-12-18 |
Genzyme Corp |
Conjugados anticorpo fármaco glicomanipulados
|
|
EP3204005A1
(en)
*
|
2014-10-10 |
2017-08-16 |
Pfizer Inc |
Synergistic auristatin combinations
|
|
IL251822B2
(en)
|
2014-10-29 |
2023-03-01 |
Teva Pharmaceuticals Australia Pty Ltd |
Variants of interferon alpha-2-b
|
|
CN107148285B
(zh)
|
2014-11-25 |
2022-01-04 |
Adc治疗股份有限公司 |
吡咯并苯并二氮杂䓬-抗体缀合物
|
|
JP6742314B2
(ja)
*
|
2014-12-03 |
2020-08-19 |
ジェネンテック， インコーポレイテッド |
抗黄色ブドウ球菌抗体リファマイシン複合体及びその使用
|
|
JP6751393B2
(ja)
*
|
2014-12-03 |
2020-09-02 |
ジェネンテック， インコーポレイテッド |
抗ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓ抗体リファマイシン抱合体及びその使用
|
|
CN107206101B
(zh)
|
2014-12-03 |
2021-06-25 |
基因泰克公司 |
季铵化合物及其抗体-药物缀合物
|
|
MX2017007629A
(es)
*
|
2014-12-09 |
2018-05-17 |
Abbvie Inc |
Compuestos inhibidores de bcl-xl que tienen una baja permeabilidad en las celulas y conjugados de anticuerpo-farmaco que los incluyen.
|
|
EP3230283A1
(en)
*
|
2014-12-09 |
2017-10-18 |
AbbVie Inc. |
Bcl-xl inhibitory compounds and antibody drug conjugates including the same
|
|
JP6862343B2
(ja)
*
|
2014-12-19 |
2021-04-21 |
アブリンクス エン．ヴェー． |
システイン結合ナノボディダイマー
|
|
EP3259285A2
(en)
*
|
2015-02-16 |
2017-12-27 |
Lonza Ltd |
Cl and/or ch1 mutated antibodies for drug conjugation
|
|
SG11201707538XA
(en)
|
2015-03-17 |
2017-10-30 |
Memorial Sloan Kettering Cancer Center |
Anti-muc16 antibodies and uses thereof
|
|
BR112017020149A8
(pt)
|
2015-03-27 |
2023-05-02 |
Regeneron Pharma |
Derivados de maitansinoide, conjugados dos mesmos e métodos de uso
|
|
EP3280806A4
(en)
|
2015-04-10 |
2018-12-05 |
Thomas Jefferson University |
Methods and compositions for treating cancers and enhancing therapeutic immunity by selectively reducing immunomodulatory m2 monocytes
|
|
GB201506402D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
GB201506389D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
GB201506411D0
(en)
|
2015-04-15 |
2015-05-27 |
Bergenbio As |
Humanized anti-axl antibodies
|
|
WO2016205176A1
(en)
*
|
2015-06-15 |
2016-12-22 |
Genentech, Inc. |
Antibodies and immunoconjugates
|
|
AU2015242213A1
(en)
|
2015-07-12 |
2018-03-08 |
Hangzhou Dac Biotech Co., Ltd |
Bridge linkers for conjugation of cell-binding molecules
|
|
US9839687B2
(en)
|
2015-07-15 |
2017-12-12 |
Suzhou M-Conj Biotech Co., Ltd. |
Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
|
|
GB201514928D0
(en)
|
2015-08-21 |
2015-10-07 |
King S College London |
PDD compounds
|
|
MA45326A
(fr)
|
2015-10-20 |
2018-08-29 |
Genentech Inc |
Conjugués calichéamicine-anticorps-médicament et procédés d'utilisation
|
|
US9669106B2
(en)
|
2015-10-26 |
2017-06-06 |
Pierre Fabre Medicament |
Conjugate of monomethyl auristatin F and trastuzumab and its use for the treatment of cancer
|
|
AU2016344663B2
(en)
|
2015-10-26 |
2023-09-07 |
Pierre Fabre Medicament |
Composition for the treatment of IGF-1R expressing cancer
|
|
AU2016377371A1
(en)
|
2015-12-21 |
2018-08-09 |
Bristol-Myers Squibb Company |
Variant antibodies for site-specific conjugation
|
|
NZ744185A
(en)
*
|
2015-12-30 |
2025-09-26 |
Kodiak Sciences Inc |
Antibodies and conjugates thereof
|
|
MA43094B1
(fr)
|
2016-01-25 |
2020-10-28 |
Regeneron Pharma |
Dérivés de maytansinoïde, leurs conjugués, et procédés d'utilisation
|
|
GB201601431D0
(en)
|
2016-01-26 |
2016-03-09 |
Medimmune Ltd |
Pyrrolobenzodiazepines
|
|
GB201602356D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
GB201602359D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
US10899836B2
(en)
*
|
2016-02-12 |
2021-01-26 |
Janssen Pharmaceutica Nv |
Method of identifying anti-VISTA antibodies
|
|
SG11201807537RA
(en)
|
2016-03-04 |
2018-09-27 |
Genentech Inc |
Process for the preparation of an antibody-rifamycin conjugate
|
|
US20170315132A1
(en)
|
2016-03-25 |
2017-11-02 |
Genentech, Inc. |
Multiplexed total antibody and antibody-conjugated drug quantification assay
|
|
CN109219610A
(zh)
*
|
2016-04-04 |
2019-01-15 |
新泽西州立拉特格斯大学 |
拓扑异构酶毒物
|
|
EP3448885A4
(en)
|
2016-04-26 |
2020-01-08 |
R.P. Scherer Technologies, LLC |
ANTIBODY CONJUGATES AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
|
GB201607478D0
(en)
|
2016-04-29 |
2016-06-15 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
US10918627B2
(en)
|
2016-05-11 |
2021-02-16 |
Massachusetts Institute Of Technology |
Convergent and enantioselective total synthesis of Communesin analogs
|
|
JP2019522633A
(ja)
|
2016-05-20 |
2019-08-15 |
ジェネンテック， インコーポレイテッド |
Ｐｒｏｔａｃ抗体コンジュゲート及び使用方法
|
|
WO2017205741A1
(en)
|
2016-05-27 |
2017-11-30 |
Genentech, Inc. |
Bioanalytical method for the characterization of site-specific antibody-drug conjugates
|
|
EP3464280B1
(en)
|
2016-06-06 |
2021-10-06 |
F. Hoffmann-La Roche AG |
Silvestrol antibody-drug conjugates and methods of use
|
|
TW202434291A
(zh)
|
2016-07-08 |
2024-09-01 |
美商建南德克公司 |
人類副睪蛋白4 (he4)用於評定癌症治療反應性之用途
|
|
CA3030926A1
(en)
|
2016-07-19 |
2018-01-25 |
Teva Pharmaceuticals Australia Pty Ltd. |
Anti-cd47 combination therapy
|
|
JP2019530434A
(ja)
|
2016-08-05 |
2019-10-24 |
ジェネンテック， インコーポレイテッド |
アゴニスト活性を有する多価及び多重エピトープ抗体ならびに使用方法
|
|
JP2019529350A
(ja)
*
|
2016-08-16 |
2019-10-17 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
混合物から個々の抗体を定量する方法
|
|
US10941208B2
(en)
|
2016-09-23 |
2021-03-09 |
Regeneron Pharmaceuticals, Inc. |
Anti-MUC16 antibodies
|
|
CN110139674B
(zh)
|
2016-10-05 |
2023-05-16 |
豪夫迈·罗氏有限公司 |
制备抗体药物缀合物的方法
|
|
CN107789630A
(zh)
*
|
2016-10-08 |
2018-03-13 |
四川百利药业有限责任公司 |
半胱氨酸改造的抗体‑毒素偶联物及其制备方法
|
|
GB201617466D0
(en)
|
2016-10-14 |
2016-11-30 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
KR20220147720A
(ko)
|
2016-11-14 |
2022-11-03 |
항저우 디에이씨 바이오테크 씨오, 엘티디 |
결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
|
|
MY191926A
(en)
|
2016-12-01 |
2022-07-18 |
Regeneron Pharma |
Radiolabeled anti-pd-l1 antibodies for immuno-pet imaging
|
|
JP7244987B2
(ja)
*
|
2016-12-14 |
2023-03-23 |
シージェン インコーポレイテッド |
多剤抗体薬物コンジュゲート
|
|
EP3544636B1
(en)
|
2017-02-08 |
2021-03-31 |
ADC Therapeutics SA |
Pyrrolobenzodiazepine-antibody conjugates
|
|
CA3047686C
(en)
|
2017-02-08 |
2020-07-07 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
|
GB201702031D0
(en)
|
2017-02-08 |
2017-03-22 |
Medlmmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
|
CA3052539C
(en)
|
2017-02-08 |
2022-08-30 |
Pfizer Inc. |
Large scale production process for capped and un-capped antibody cysteines and their use in therapeutic protein conjugation
|
|
JP2020517609A
(ja)
|
2017-04-18 |
2020-06-18 |
メディミューン リミテッド |
ピロロベンゾジアゼピン複合体
|
|
ES2977788T3
(es)
|
2017-04-20 |
2024-08-30 |
Adc Therapeutics Sa |
Terapia combinada con un conjugado de anticuerpo anti-AXL y fármaco
|
|
AU2018258045B2
(en)
|
2017-04-26 |
2024-02-29 |
Eureka Therapeutics, Inc. |
Chimeric antibody/T-cell receptor constructs and uses thereof
|
|
WO2018209239A1
(en)
|
2017-05-11 |
2018-11-15 |
Massachusetts Institute Of Technology |
Potent agelastatin derivatives as modulators for cancer invasion and metastasis
|
|
WO2018210824A1
(en)
*
|
2017-05-16 |
2018-11-22 |
Universite De Strasbourg |
Protein-drug conjugates and their use in the treatment of cancers
|
|
US11318211B2
(en)
|
2017-06-14 |
2022-05-03 |
Adc Therapeutics Sa |
Dosage regimes for the administration of an anti-CD19 ADC
|
|
AU2018288029B2
(en)
*
|
2017-06-19 |
2021-12-23 |
Systimmune, Inc. |
Antibody-drug conjugate having acidic self-stabilization junction
|
|
AU2018288030B2
(en)
*
|
2017-06-20 |
2022-02-03 |
Systimmune, Inc. |
Screening of fixed-point coupling sites of cysteine-modified antibody-toxin conjugate (TDC)
|
|
SMT202400503T1
(it)
*
|
2017-08-04 |
2025-01-14 |
Amgen Inc |
Metodo di coniugazione di cys-mab
|
|
EA039276B1
(ru)
|
2017-08-18 |
2021-12-27 |
Медимьюн Лимитед |
Пирролобензодиазепиновые конъюгаты
|
|
CN107583058B
(zh)
*
|
2017-09-20 |
2020-09-18 |
厉保秋 |
一种t-2毒素-抗体缀合物及其用途
|
|
US11364303B2
(en)
|
2017-09-29 |
2022-06-21 |
Pfizer Inc. |
Cysteine engineered antibody drug conjugates
|
|
US10640508B2
(en)
|
2017-10-13 |
2020-05-05 |
Massachusetts Institute Of Technology |
Diazene directed modular synthesis of compounds with quaternary carbon centers
|
|
EP3700901A1
(en)
|
2017-10-24 |
2020-09-02 |
Genentech, Inc. |
(4-hydroxypyrrolidin-2-yl)-heterocyclic compounds and methods of use thereof
|
|
WO2019084030A1
(en)
|
2017-10-24 |
2019-05-02 |
Genentech, Inc. |
(4-HYDROXYPYRROLIDIN-2-YL) -HYDROXAMATE COMPOUNDS AND METHODS OF USE
|
|
US11865182B2
(en)
|
2017-11-18 |
2024-01-09 |
Nzola DE MAGALHAES |
Product and process for employing GC7 (N1-guanyl-1,7-diaminoheptane) based antigen binding conjugates in cancer therapy
|
|
CN115639361B
(zh)
*
|
2018-02-09 |
2025-07-18 |
北京豪迈生物工程股份有限公司 |
表面结合有抗体的颗粒
|
|
GB201803342D0
(en)
|
2018-03-01 |
2018-04-18 |
Medimmune Ltd |
Methods
|
|
WO2019183523A1
(en)
|
2018-03-23 |
2019-09-26 |
Genentech, Inc. |
Hetero-bifunctional degrader compounds and their use as modulators of targeted ubiquination (vhl)
|
|
GB201806022D0
(en)
|
2018-04-12 |
2018-05-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
CN108714220B
(zh)
*
|
2018-04-24 |
2021-11-19 |
四川百利药业有限责任公司 |
半胱氨酸改造的抗体-毒素偶联物
|
|
CN108743966B
(zh)
*
|
2018-04-24 |
2021-10-19 |
四川百利药业有限责任公司 |
半胱氨酸改造的抗体-毒素偶联物
|
|
CN108727498B
(zh)
*
|
2018-04-24 |
2021-11-26 |
四川百利药业有限责任公司 |
半胱氨酸改造的抗体-毒素偶联物
|
|
CN108727499B
(zh)
*
|
2018-04-24 |
2021-12-31 |
四川百利药业有限责任公司 |
半胱氨酸改造的抗体-毒素偶联物
|
|
JP2021525534A
(ja)
|
2018-06-04 |
2021-09-27 |
プレシゲン，インコーポレイテッド |
Ｍｕｃ１６特異的キメラ抗原受容体およびそれらの使用
|
|
GB201814281D0
(en)
|
2018-09-03 |
2018-10-17 |
Femtogenix Ltd |
Cytotoxic agents
|
|
TWI888359B
(zh)
|
2018-09-11 |
2025-07-01 |
瑞士商赫孚孟拉羅股份公司 |
噻吩并－三唑并－二氮呯醋酸酯
|
|
CN112867510A
(zh)
|
2018-10-19 |
2021-05-28 |
免疫医疗有限公司 |
吡咯并苯并二氮杂䓬缀合物
|
|
JP2022512716A
(ja)
|
2018-10-19 |
2022-02-07 |
メドイミューン・リミテッド |
ピロロベンゾジアゼピン複合体
|
|
JP2022513198A
(ja)
|
2018-12-10 |
2022-02-07 |
ジェネンテック， インコーポレイテッド |
Ｆｃ含有タンパク質への部位特異的コンジュゲーションのための光架橋性ペプチド
|
|
CN119896730A
(zh)
|
2018-12-17 |
2025-04-29 |
雷维托普有限公司 |
双免疫细胞衔接物
|
|
TWI874341B
(zh)
|
2018-12-18 |
2025-03-01 |
美商健生生物科技公司 |
產生異二聚體抗體之方法
|
|
GB201901197D0
(en)
|
2019-01-29 |
2019-03-20 |
Femtogenix Ltd |
G-A Crosslinking cytotoxic agents
|
|
US12109273B2
(en)
|
2019-02-15 |
2024-10-08 |
Wuxi Xdc Singapore Private Limited |
Process for preparing antibody-drug conjugates with improved homogeneity
|
|
WO2020164561A1
(en)
|
2019-02-15 |
2020-08-20 |
Wuxi Biologics (Shanghai) Co. Ltd. |
Process for preparing antibody-drug conjugates with improved homogeneity
|
|
BR112021018260A2
(pt)
|
2019-03-15 |
2021-11-23 |
Medimmune Ltd |
Dímeros de azetidobenzodiazepina e conjugados compreendendo-os para uso no tratamento de câncer
|
|
RS63715B1
(sr)
|
2019-03-29 |
2022-11-30 |
Medimmune Ltd |
Jedinjenja i njihovi konjugati
|
|
MA55529A
(fr)
|
2019-04-03 |
2022-02-09 |
Genzyme Corp |
Polypeptides de liaison anti-alpha bêta tcr à fragmentation réduite
|
|
CN111825742B
(zh)
*
|
2019-04-18 |
2024-01-30 |
陈铭 |
Ctpa作为特种偶合剂用于氨基酸离子液体的多肽固相合成
|
|
WO2020247054A1
(en)
|
2019-06-05 |
2020-12-10 |
Massachusetts Institute Of Technology |
Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof
|
|
GB201908128D0
(en)
|
2019-06-07 |
2019-07-24 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
|
EP3983082A1
(en)
|
2019-06-13 |
2022-04-20 |
Bolt Biotherapeutics, Inc. |
Aminobenzazepine compounds, immunoconjugates, and uses thereof
|
|
CA3145050A1
(en)
|
2019-06-29 |
2021-01-07 |
Robert Zhao |
Conjugates of tubulysin derivatives and cell binding molecules and methods of making
|
|
CN114630684A
(zh)
|
2019-09-03 |
2022-06-14 |
博尔特生物治疗药物有限公司 |
氨基喹啉化合物、免疫缀合物及其用途
|
|
MX2022003740A
(es)
|
2019-09-30 |
2022-05-02 |
Bolt Biotherapeutics Inc |
Inmunoconjugados de aminobenzazepina unidos a amida y usos de estos.
|
|
WO2021072265A1
(en)
|
2019-10-10 |
2021-04-15 |
Kodiak Sciences Inc. |
Methods of treating an eye disorder
|
|
EP4048315B1
(en)
|
2019-10-25 |
2025-03-12 |
Bolt Biotherapeutics, Inc. |
Thienoazepine immunoconjugates, and uses thereof
|
|
WO2021080608A1
(en)
|
2019-10-25 |
2021-04-29 |
Medimmune, Llc |
Branched moiety for use in conjugates
|
|
CN110922476A
(zh)
*
|
2019-12-16 |
2020-03-27 |
蓝怡科技集团股份有限公司 |
一种生物素偶联抗体及其制备方法和应用
|
|
MX2022009052A
(es)
|
2020-01-22 |
2022-08-15 |
Medimmune Ltd |
Compuestos y conjugados de estos.
|
|
TW202140076A
(zh)
|
2020-01-22 |
2021-11-01 |
英商梅迪繆思有限公司 |
化合物及其軛合物
|
|
WO2021226440A1
(en)
|
2020-05-08 |
2021-11-11 |
Bolt Biotherapeutics, Inc. |
Elastase-substrate, peptide linker immunoconjugates, and uses thereof
|
|
GB2597532A
(en)
|
2020-07-28 |
2022-02-02 |
Femtogenix Ltd |
Cytotoxic compounds
|
|
GB202011993D0
(en)
|
2020-07-31 |
2020-09-16 |
Adc Therapeutics Sa |
ANTI-IL 13Ra2 antibodies
|
|
IL300316A
(en)
|
2020-08-13 |
2023-04-01 |
Bolt Biotherapeutics Inc |
Immune conjugates of pyrazolozapines and their uses
|
|
EP4208259A2
(en)
|
2020-09-04 |
2023-07-12 |
NovaRock Biotherapeutics, Ltd. |
Nectin-4 antibodies and uses thereof
|
|
CN116829592A
(zh)
|
2020-09-11 |
2023-09-29 |
免疫医疗有限公司 |
治疗性b7-h4结合分子
|
|
EP4259210A2
(en)
|
2020-12-11 |
2023-10-18 |
Bolt Biotherapeutics, Inc. |
Anti-cea immunoconjugates, and uses thereof
|
|
JP2023552792A
(ja)
|
2020-12-11 |
2023-12-19 |
ボルト バイオセラピューティクス、インコーポレーテッド |
抗ｈｅｒ２免疫複合体、及びその使用
|
|
US20220195066A1
(en)
|
2020-12-11 |
2022-06-23 |
Bolt Biotherapeutics, Inc. |
Anti-cea immunoconjugates, and uses thereof
|
|
KR20230118149A
(ko)
|
2020-12-11 |
2023-08-10 |
볼트 바이오테라퓨틱스 인코퍼레이티드 |
항-pd-l1 면역접합체, 및 그의 용도
|
|
EP4259211A1
(en)
|
2020-12-11 |
2023-10-18 |
Bolt Biotherapeutics, Inc. |
Anti-her2 immunoconjugates, and uses thereof
|
|
EP4046996A1
(en)
|
2021-02-19 |
2022-08-24 |
Universität Bielefeld |
Cryptophycin compounds and conjugates thereof
|
|
CN114957476A
(zh)
*
|
2021-02-23 |
2022-08-30 |
复旦大学 |
一种半胱氨酸工程化的结合人5t4的全人源纳米抗体
|
|
US12030888B2
(en)
|
2021-02-24 |
2024-07-09 |
Massachusetts Institute Of Technology |
Himastatin derivatives, and processes of preparation thereof, and uses thereof
|
|
WO2022197877A1
(en)
|
2021-03-19 |
2022-09-22 |
Genentech, Inc. |
Methods and compositions for time delayed bio-orthogonal release of cytotoxic agents
|
|
WO2022204528A1
(en)
|
2021-03-26 |
2022-09-29 |
Bolt Biotherapeutics, Inc. |
2-amino-4-carboxamide-benzazepine immunoconjugates, and uses thereof
|
|
WO2022204536A1
(en)
|
2021-03-26 |
2022-09-29 |
Bolt Biotherapeutics, Inc. |
2-amino-4-carboxamide-benzazepine immunoconjugates, and uses thereof
|
|
GB202105187D0
(en)
|
2021-04-12 |
2021-05-26 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
JP2024517409A
(ja)
*
|
2021-04-16 |
2024-04-22 |
ノバルティス アーゲー |
抗体薬物結合体及びその作成方法
|
|
EP4422697A1
(en)
|
2021-10-29 |
2024-09-04 |
Bolt Biotherapeutics, Inc. |
Tlr agonist immunoconjugates with cysteine-mutant antibodies, and uses thereof
|
|
EP4426727A2
(en)
|
2021-11-03 |
2024-09-11 |
Hangzhou Dac Biotech Co., Ltd. |
Specific conjugation of an antibody
|
|
KR20240099430A
(ko)
|
2021-11-10 |
2024-06-28 |
아스트라제네카 아베 |
항체 분자 및 접합체
|
|
US20230285580A1
(en)
|
2021-11-19 |
2023-09-14 |
Adc Therapeutics Sa |
Anti-il-13ralpha2 conjugates
|
|
US20230201366A1
(en)
|
2021-11-19 |
2023-06-29 |
Adc Therapeutics Sa |
Anti-psma conjugates
|
|
TW202348252A
(zh)
|
2022-02-16 |
2023-12-16 |
英商梅迪繆思有限公司 |
用治療性結合分子治療癌症的組合療法
|
|
EP4230222A1
(en)
|
2022-02-17 |
2023-08-23 |
Oxsonics Limited |
Combination therapy with an anti-axl antibody-pbd conjugate and nanocups
|
|
IL315178A
(en)
|
2022-02-28 |
2024-10-01 |
Adc Therapeutics Sa |
Dosage regimen
|
|
AU2023229884A1
(en)
|
2022-03-09 |
2024-10-10 |
Astrazeneca Ab |
BINDING MOLECULES AGAINST FRα
|
|
KR20240162086A
(ko)
|
2022-03-11 |
2024-11-14 |
아스트라제네카 아베 |
항-FRα 항체-약물 접합체 치료법에 대한 점수 산정 방법
|
|
TW202417040A
(zh)
|
2022-06-27 |
2024-05-01 |
瑞典商阿斯特捷利康公司 |
涉及用於治療癌症的上皮生長因子受體酪胺酸激酶抑制劑之組合
|
|
CA3261509A1
(en)
|
2022-09-09 |
2024-03-14 |
Imperial College Innovations Limited |
CYTOTOXIC IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AND THEIR USE IN THERAPY
|
|
KR20250099224A
(ko)
|
2022-11-01 |
2025-07-01 |
하이델베르크 파마 리서치 게엠베하 |
항-gucy2c 항체 및 이의 용도
|
|
EP4634227A1
(en)
*
|
2022-12-13 |
2025-10-22 |
Seagen Inc. |
Site-specific engineered cysteine antibody drug conjugates
|
|
CN121002040A
(zh)
|
2022-12-14 |
2025-11-21 |
费恩治疗有限公司 |
细胞毒性化合物
|
|
WO2024137619A1
(en)
|
2022-12-20 |
2024-06-27 |
Bolt Biotherapeutics, Inc. |
Anti-claudin, bis-benzimid azole sting agonist immunoconjugates, and uses thereof
|
|
CN120417934A
(zh)
|
2022-12-23 |
2025-08-01 |
基因泰克公司 |
Cereblon降解剂缀合物及其用途
|
|
EP4410314A1
(en)
|
2023-02-02 |
2024-08-07 |
ADC Therapeutics SA |
Combination therapy comprising anti-cd22 antibody-drug conjugate and irak1 inhibitor
|
|
WO2024173387A1
(en)
|
2023-02-14 |
2024-08-22 |
Bolt Biotherapeutics, Inc. |
Aza-benzazepine immunoconjugates, and uses thereof
|
|
CN120936382A
(zh)
|
2023-02-16 |
2025-11-11 |
阿斯利康(瑞典)有限公司 |
采用治疗性结合分子治疗癌症的组合疗法
|
|
WO2024186626A1
(en)
|
2023-03-03 |
2024-09-12 |
Bolt Biotherapeutics, Inc. |
Aza-bicyclic sting agonist immunoconjugates, and uses thereof
|
|
KR20250152101A
(ko)
|
2023-03-13 |
2025-10-22 |
하이델베르크 파마 리서치 게엠베하 |
암 치료에의 사용을 위한 피하 투여 항체-약물 접합체
|
|
TW202506194A
(zh)
|
2023-04-28 |
2025-02-16 |
英商梅迪繆思有限公司 |
用於治療癌症的ｂ７－ｈ４治療性結合分子
|
|
WO2025083067A1
(en)
|
2023-10-17 |
2025-04-24 |
Adc Therapeutics Sa |
Anti-claudin-6 conjugates
|
|
WO2025083064A1
(en)
|
2023-10-17 |
2025-04-24 |
Adc Therapeutics Sa |
Anti-asct2 conjugates
|
|
WO2025083061A1
(en)
|
2023-10-17 |
2025-04-24 |
Adc Therapeutics Sa |
Anti-napi2b conjugates
|
|
EP4548936A1
(en)
*
|
2023-10-30 |
2025-05-07 |
BioNTech SE |
Antibody-drug conjugates having a tailor-made drug-to-antibody ratio
|
|
WO2025109097A2
(en)
|
2023-11-24 |
2025-05-30 |
Heidelberg Pharma Research Gmbh |
Novel nicotinamide phosphoribosyltransferase inhibitors and uses thereof
|
|
US20250186604A1
(en)
|
2023-12-06 |
2025-06-12 |
Adc Therapeutics Sa |
Anti-psma antibody conjugates
|
|
EP4566631A1
(en)
|
2023-12-06 |
2025-06-11 |
Heidelberg Pharma Research GmbH |
New antibody drug conjugate as well as methods of production and uses thereof
|
|
WO2025134068A1
(en)
|
2023-12-22 |
2025-06-26 |
Ac Immune Sa |
Antibody drug conjugates targeting proteinopathies, and uses thereof
|
|
WO2025149667A1
(en)
|
2024-01-12 |
2025-07-17 |
Pheon Therapeutics Ltd |
Antibody drug conjugates and uses thereof
|
|
EP4596569A1
(en)
*
|
2024-02-05 |
2025-08-06 |
Syndivia |
Site specific antibody drug conjugates and their process of preparation
|
|
GB202403391D0
(en)
|
2024-03-08 |
2024-04-24 |
Myricx Pharma Ltd |
Novel compounds and their use in therapy
|
|
GB202405758D0
(en)
|
2024-04-24 |
2024-06-05 |
King S College London |
Compounds
|
|
GB202407700D0
(en)
|
2024-05-30 |
2024-07-17 |
Francis Crick Institute Ltd |
F-actin binding agents
|
|
WO2026006688A2
(en)
|
2024-06-28 |
2026-01-02 |
Firefly Bio, Inc. |
Degrader antibody conjugates and uses thereof
|
|
WO2026006689A2
(en)
|
2024-06-28 |
2026-01-02 |
Firefly Bio, Inc. |
Bcl-xl degrader antibody conjugates and uses thereof
|